• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C反应蛋白-白蛋白-淋巴细胞(CALLY)指数对胰十二指肠切除术后远端胆管癌患者预后的影响

The impact of C-reactive protein-albumin-lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy.

作者信息

Tsunematsu Masashi, Haruki Koichiro, Taniai Tomohiko, Tanji Yoshiaki, Shirai Yoshihiro, Furukawa Kenei, Uwagawa Tadashi, Onda Shinji, Yanagaki Mitsuru, Usuba Teruyuki, Nakabayashi Yukio, Okamoto Tomoyoshi, Ikegami Toru

机构信息

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery The Jikei University School of Medicine Tokyo Japan.

Department of Surgery The Jikei University Katsushika Medical Center Tokyo Japan.

出版信息

Ann Gastroenterol Surg. 2022 Nov 18;7(3):503-511. doi: 10.1002/ags3.12637. eCollection 2023 May.

DOI:10.1002/ags3.12637
PMID:37152771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10154875/
Abstract

AIM

The C-reactive protein (CRP)-albumin-lymphocyte (CALLY) index is a novel inflammation-based biomarker, which has been associated with long-term outcomes in patients with hepatocellular carcinoma. We aimed to investigate whether the CALLY index can predict the prognosis for distal cholangiocarcinoma after pancreaticoduodenectomy.

METHODS

The study comprised 143 patients who had undergone primary pancreaticoduodenectomy for distal cholangiocarcinoma between 2002 to 2019. The CALLY index was defined as (albumin × lymphocyte)/ (CRP × 10). We investigated the association of CALLY index with disease-free survival and overall survival by univariate and multivariate analyses.

RESULTS

Eighty-seven (61%) patients had a preoperative CALLY index <3.5. In multivariate analysis, obstructive jaundice drainage ( < .01), poorly differentiated tumor ( < .01), and CALLY index<3.5 ( = .02) were independent predictors of disease-free survival, while obstructive jaundice drainage ( < .01), poorly differentiated tumor ( < .01), and CALLY index <3.5 ( = .02) were independent predictors of overall survival.

CONCLUSION

The CALLY index may be an independent and significant indicator of poor long-term outcomes in patients with distal cholangiocarcinoma after pancreaticoduodenectomy, suggesting the importance of comprehensive assessment for inflammatory status.

摘要

目的

C反应蛋白(CRP)-白蛋白-淋巴细胞(CALLY)指数是一种基于炎症的新型生物标志物,已被证明与肝细胞癌患者的长期预后相关。我们旨在研究CALLY指数能否预测胰十二指肠切除术后远端胆管癌的预后。

方法

本研究纳入了2002年至2019年间因远端胆管癌接受初次胰十二指肠切除术的143例患者。CALLY指数定义为(白蛋白×淋巴细胞)/(CRP×10)。我们通过单因素和多因素分析研究CALLY指数与无病生存期和总生存期的关系。

结果

87例(61%)患者术前CALLY指数<3.5。在多因素分析中,梗阻性黄疸引流(<0.01)、低分化肿瘤(<0.01)和CALLY指数<3.5(=0.02)是无病生存期的独立预测因素,而梗阻性黄疸引流(<0.01)、低分化肿瘤(<0.01)和CALLY指数<3.5(=0.02)是总生存期的独立预测因素。

结论

CALLY指数可能是胰十二指肠切除术后远端胆管癌患者长期预后不良的独立且重要指标,提示对炎症状态进行综合评估的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b7/10154875/a8f05ca26112/AGS3-7-503-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b7/10154875/cd67cd7f57d7/AGS3-7-503-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b7/10154875/fc4bd0677e23/AGS3-7-503-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b7/10154875/a8f05ca26112/AGS3-7-503-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b7/10154875/cd67cd7f57d7/AGS3-7-503-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b7/10154875/fc4bd0677e23/AGS3-7-503-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b7/10154875/a8f05ca26112/AGS3-7-503-g001.jpg

相似文献

1
The impact of C-reactive protein-albumin-lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy.C反应蛋白-白蛋白-淋巴细胞(CALLY)指数对胰十二指肠切除术后远端胆管癌患者预后的影响
Ann Gastroenterol Surg. 2022 Nov 18;7(3):503-511. doi: 10.1002/ags3.12637. eCollection 2023 May.
2
Impact of C-reactive protein-albumin-lymphocyte (CALLY) index on prognosis after hepatectomy for colorectal liver metastasis.C反应蛋白-白蛋白-淋巴细胞(CALLY)指数对结直肠癌肝转移肝切除术后预后的影响
Surg Oncol. 2023 Apr;47:101911. doi: 10.1016/j.suronc.2023.101911. Epub 2023 Feb 8.
3
Prognostic usefulness of the C-reactive protein-albumin-lymphocyte (CALLY) index as a novel biomarker in patients undergoing colorectal cancer surgery.C 反应蛋白-白蛋白-淋巴细胞(CALLY)指数作为结直肠癌手术患者新型生物标志物的预后价值。
Asian J Surg. 2024 Aug;47(8):3492-3498. doi: 10.1016/j.asjsur.2024.03.054. Epub 2024 Mar 26.
4
Usefulness of the C-Reactive Protein (CRP)-Albumin-Lymphocyte (CALLY) Index as a Prognostic Indicator for Patients With Gastric Cancer.C 反应蛋白(CRP)-白蛋白-淋巴细胞(CALLY)指数作为胃癌患者预后指标的效用。
Am Surg. 2024 Nov;90(11):2703-2709. doi: 10.1177/00031348241248693. Epub 2024 Apr 21.
5
Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma.CRP-白蛋白-淋巴细胞指数(CALLY 指数)作为肝癌肝切除术后非侵入性预后生物标志物的优越性。
HPB (Oxford). 2022 Jan;24(1):101-115. doi: 10.1016/j.hpb.2021.06.414. Epub 2021 Jun 22.
6
Prognostic significance of the preoperative C-reactive protein-albumin-lymphocyte (CALLY) index on outcomes after gastrectomy for gastric cancer.术前 C 反应蛋白-白蛋白-淋巴细胞(CALLY)指数对胃癌胃切除术后结局的预后意义。
Surg Today. 2024 Aug;54(8):943-952. doi: 10.1007/s00595-024-02813-1. Epub 2024 Mar 15.
7
Pre-Treatment CRP-Albumin-Lymphocyte Index (CALLY Index) as a Prognostic Biomarker of Survival in Patients with Epithelial Ovarian Cancer.治疗前C反应蛋白-白蛋白-淋巴细胞指数(CALLY指数)作为上皮性卵巢癌患者生存的预后生物标志物
Cancer Manag Res. 2022 Sep 19;14:2803-2812. doi: 10.2147/CMAR.S359968. eCollection 2022.
8
Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Breast Cancer.CRP-白蛋白-淋巴细胞(CALLY)指数在乳腺癌手术患者中的预后价值
Int J Gen Med. 2024 Mar 15;17:997-1005. doi: 10.2147/IJGM.S447201. eCollection 2024.
9
Association between the C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index and Adverse Clinical Outcomes in CAD Patients after PCI: Findings of a Real-World Study.C反应蛋白-白蛋白-淋巴细胞(CALLY)指数与PCI术后CAD患者不良临床结局的关联:一项真实世界研究的结果
Rev Cardiovasc Med. 2024 Mar 25;25(4):111. doi: 10.31083/j.rcm2504111. eCollection 2024 Apr.
10
Clinical implications of C-reactive protein-albumin-lymphocyte (CALLY) index in patients with esophageal cancer.C 反应蛋白-白蛋白-淋巴细胞(CALLY)指数对食管癌患者的临床意义。
Surg Oncol. 2024 Apr;53:102044. doi: 10.1016/j.suronc.2024.102044. Epub 2024 Feb 5.

引用本文的文献

1
Prognostic Impact of C-reactive Protein-Albumin-Lymphocyte Index in Patients Who Underwent Splenectomy and Devascularization for Gastric Varices Caused by Portal Hypertension.C反应蛋白-白蛋白-淋巴细胞指数对因门静脉高压导致胃静脉曲张而行脾切除及去血管化治疗患者的预后影响
Cureus. 2025 Jul 1;17(7):e87092. doi: 10.7759/cureus.87092. eCollection 2025 Jul.
2
Value of CRP, albumin, and lymphocyte index in predicting survival of patients with gastrointestinal malignancies: a systematic review and meta-analysis.C反应蛋白、白蛋白和淋巴细胞指数在预测胃肠道恶性肿瘤患者生存率中的价值:一项系统评价和荟萃分析
Front Oncol. 2025 Jul 16;15:1592794. doi: 10.3389/fonc.2025.1592794. eCollection 2025.
3

本文引用的文献

1
The impact of S-1 for the patient with lymph nodal metastasis biliary tract cancer as adjuvant chemotherapy: a multicenter database analysis.S-1 作为辅助化疗用于伴有淋巴结转移的胆道癌患者的影响:一项多中心数据库分析。
Int J Clin Oncol. 2022 Jul;27(7):1188-1195. doi: 10.1007/s10147-022-02165-1. Epub 2022 Apr 15.
2
Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index.经动脉化疗栓塞的肝细胞癌患者的免疫营养评分:CALLY指数评估
Cancers (Basel). 2021 Oct 7;13(19):5018. doi: 10.3390/cancers13195018.
3
Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma.
The CRP-albumin-lymphocyte index provides enhanced prognostic value in liver cancer compared to the TNM staging system.
与TNM分期系统相比,C反应蛋白-白蛋白-淋巴细胞指数在肝癌中具有更高的预后价值。
Sci Rep. 2025 Jun 19;15(1):20090. doi: 10.1038/s41598-025-03985-7.
4
C-reactive Protein-albumin-lymphocyte Index Is a Useful Indicator for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer.C反应蛋白-白蛋白-淋巴细胞指数是I-III期结肠癌根治性切除术后复发和生存的有用指标。
J Anus Rectum Colon. 2025 Apr 25;9(2):192-201. doi: 10.23922/jarc.2024-070. eCollection 2025.
5
Integrating inflammation, nutrition, and immunity: the CALLY index as a prognostic tool in digestive system cancers - a systematic review and meta-analysis.整合炎症、营养与免疫:CALLY指数作为消化系统癌症预后工具的系统评价与荟萃分析
BMC Cancer. 2025 Apr 11;25(1):672. doi: 10.1186/s12885-025-14074-3.
6
Prognostic and clinicopathological significance of C-reactive protein-albumin-lymphocyte(CALLY) in patients with digestive system neoplasms: a systematic review and meta-analysis.C反应蛋白-白蛋白-淋巴细胞(CALLY)在消化系统肿瘤患者中的预后及临床病理意义:一项系统评价和荟萃分析
World J Surg Oncol. 2025 Apr 2;23(1):114. doi: 10.1186/s12957-025-03779-1.
7
Associations of the C-reactive protein-albumin-lymphocyte index with all-cause and cardiovascular mortality among individuals with cardiovascular disease: evidence from the NHANES 2001-2010.心血管疾病患者中C反应蛋白-白蛋白-淋巴细胞指数与全因死亡率和心血管死亡率的关联:来自2001 - 2010年美国国家健康与营养检查调查的证据
BMC Cardiovasc Disord. 2025 Mar 3;25(1):144. doi: 10.1186/s12872-025-04596-w.
8
Blood Cell Ratio Combinations for Diagnosing Periprosthetic Joint Infections: A Preliminary Study.用于诊断人工关节周围感染的血细胞比容组合:一项初步研究。
Infect Drug Resist. 2025 Feb 1;18:635-645. doi: 10.2147/IDR.S489201. eCollection 2025.
9
Association between the C-reactive protein-albumin-lymphocyte index and metabolic syndrome: evidence from the 2003-2010 national health and nutrition examination survey.C反应蛋白-白蛋白-淋巴细胞指数与代谢综合征之间的关联:来自2003 - 2010年国家健康与营养检查调查的证据。
Diabetol Metab Syndr. 2025 Jan 31;17(1):39. doi: 10.1186/s13098-025-01609-8.
10
IINS Vs CALLY Index: A Battle of Prognostic Value in NSCLC Patients Following Surgery.IINS与CALLY指数:非小细胞肺癌患者术后预后价值的较量
J Inflamm Res. 2025 Jan 10;18:493-503. doi: 10.2147/JIR.S490130. eCollection 2025.
CRP-白蛋白-淋巴细胞指数(CALLY 指数)作为肝癌肝切除术后非侵入性预后生物标志物的优越性。
HPB (Oxford). 2022 Jan;24(1):101-115. doi: 10.1016/j.hpb.2021.06.414. Epub 2021 Jun 22.
4
The novel index using preoperative C-reactive protein and neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with pancreatic cancer.新型术前 C 反应蛋白与中性粒细胞/淋巴细胞比值指数可预测胰腺癌患者的不良预后。
Int J Clin Oncol. 2021 Oct;26(10):1922-1928. doi: 10.1007/s10147-021-01964-2. Epub 2021 Jun 10.
5
Risk Stratification of Cholangiocarcinoma Patients Presenting with Jaundice: A Retrospective Analysis from a Tertiary Referral Center.以黄疸为表现的胆管癌患者的风险分层:来自三级转诊中心的回顾性分析
Cancers (Basel). 2021 Apr 25;13(9):2070. doi: 10.3390/cancers13092070.
6
Targeting cancer-promoting inflammation - have anti-inflammatory therapies come of age?靶向促进癌症的炎症——抗炎疗法是否已经成熟?
Nat Rev Clin Oncol. 2021 May;18(5):261-279. doi: 10.1038/s41571-020-00459-9. Epub 2021 Jan 19.
7
Use of preoperative controlling nutritional status (CONUT) score as a better prognostic marker for distal cholangiocarcinoma after pancreatoduodenectomy.术前控制营养状况(CONUT)评分可作为胰十二指肠切除术后远端胆管癌的更好预后标志物。
Surg Today. 2021 Mar;51(3):358-365. doi: 10.1007/s00595-020-02098-0. Epub 2020 Aug 6.
8
Preoperative C-reactive protein-to-albumin ratio predicts long-term outcomes in extrahepatic cholangiocarcinoma patients.术前 C 反应蛋白与白蛋白比值预测肝外胆管癌患者的长期预后。
J Surg Oncol. 2020 Nov;122(6):1094-1105. doi: 10.1002/jso.26109. Epub 2020 Jul 7.
9
Verification of inflammation-based prognostic marker as a prognostic indicator in hepatocellular carcinoma.基于炎症的预后标志物作为肝细胞癌预后指标的验证。
Ann Gastroenterol Surg. 2019 Sep 20;3(6):667-675. doi: 10.1002/ags3.12286. eCollection 2019 Nov.
10
Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer.预后营养指数、肿瘤浸润淋巴细胞与食管癌患者预后的关系。
Ann Surg. 2020 Apr;271(4):693-700. doi: 10.1097/SLA.0000000000002985.